1. Home
  2. CKX vs EVAX Comparison

CKX vs EVAX Comparison

Compare CKX & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

N/A

Current Price

$10.70

Market Cap

23.5M

Sector

Energy

ML Signal

N/A

Logo Evaxion Biotech

EVAX

Evaxion Biotech

HOLD

Current Price

$3.24

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CKX
EVAX
Founded
1930
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.5M
25.9M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CKX
EVAX
Price
$10.70
$3.24
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
4.5K
11.4K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
1125.00
N/A
EPS
0.09
N/A
Revenue
$838,543.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$328.20
P/E Ratio
$117.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.66
$2.52
52 Week High
$13.00
$12.15

Technical Indicators

Market Signals
Indicator
CKX
EVAX
Relative Strength Index (RSI) 47.45 61.23
Support Level $10.21 $2.93
Resistance Level $11.31 $3.61
Average True Range (ATR) 0.51 0.16
MACD -0.03 0.06
Stochastic Oscillator 26.60 83.61

Price Performance

Historical Comparison
CKX
EVAX

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way, and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. It has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Timber segment.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: